Multiple myeloma (MM) is a B-cell malignancy characterized by an accumulati
on of malignant plasma cells in the bone marrow. It is unclear whether gene
tic background could have an etiological impact on MM or influence the cour
se of the disease. Interleukin-10 (IL-10) has been implicated in the growth
and differentiation of normal B cells, and has also been shown to enhance
the proliferation of MM cells. To address the putative involvement of IL-10
genetic variation in MM, we analyzed previously defined loci for bi-alleli
c polymorphism at position -1082 and two microsatellite loci (IL10.G and IL
10.R) in the IL-10 promoter region. Seventy-three patients with MM, 27 with
monoclonal gammopathy of undetermined significance, and 109 ethnically mat
ched individuals as controls were included in the study, Significantly incr
eased frequencies of the IL10.G genotype 136/136 and the IL10.R genotype 11
2/114, in addition to a decreased frequency of the IL10.R genotype 114/116,
were found among the MM patients. Increased production of IL-10 was detect
ed in the supernatants of lipopolysaccharide-stimulated peripheral blood mo
nonuclear cells from MM patients who were homozygotes (136/136) and heteroz
ygotes (136/non-136) for the IL10.G allele 136, as compared with the other
IL10.G genotype carriers (non-136/non-136). These results suggest that the
genetic variation in the IL-10 promoter region may play a role in the devel
opment of MM, (C) 2001 Wiley-Liss, Inc.